Followers | 253 |
Posts | 50434 |
Boards Moderated | 41 |
Alias Born | 08/29/2007 |
Saturday, May 04, 2024 3:37:53 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent TNGX News
- Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program • PR Newswire (US) • 05/23/2024 01:18:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 11:18:55 AM
- Tango Therapeutics Announces Discontinuation of TNG348 Program • Business Wire • 05/23/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 11:21:05 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 11:14:59 AM
- Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights • Business Wire • 05/08/2024 11:00:00 AM
- Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/01/2024 08:48:00 PM
- Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights • Business Wire • 03/18/2024 11:00:00 AM
- Tango Therapeutics to Participate in Upcoming Investor Conferences • Business Wire • 03/06/2024 12:00:00 PM
- Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024 • GlobeNewswire Inc. • 03/05/2024 09:47:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 02:09:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 02:04:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 12:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:22:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:19:40 PM
- Tango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference • GlobeNewswire Inc. • 01/31/2024 12:00:00 PM
- Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 01/05/2024 09:05:00 PM
- Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study • PR Newswire (US) • 01/04/2024 07:47:00 AM
- Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG348 in Patients with BRCA1/2-Mutant and Other HRD+ Cancers • GlobeNewswire Inc. • 01/03/2024 12:00:00 PM
- Tango Therapeutics to Highlight Preclinical Data on PRMT5 Inhibitors at the Society for Neuro-Oncology (SNO) 28th Annual Meeting • GlobeNewswire Inc. • 11/13/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 12:29:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 12:07:56 PM
- Tango Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Highlights • GlobeNewswire Inc. • 11/08/2023 12:00:00 PM
- Tango Therapeutics to Present at the Jefferies London Healthcare Conference • GlobeNewswire Inc. • 11/07/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/02/2023 08:49:54 PM
FEATURED Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM